Browsing: Oncology

What You Should Know Paris-based precision oncology company Cureety has acquired Nashville-based Reimagine Care, uniting therapy-specific remote clinical intelligence with…

What You Should Know Value-based oncology navigation and management leader Thyme Care announced a Series E financing round exceeding $125M,…

What You Should Know Oncology drug development platform N-Power Medicine closed a $32M Series B financing round to scale its…

What You Should Know Craif Inc., a bio-AI company developing a non-invasive urine analysis platform for early cancer detection, closed…

What You Should Know Tempus AI, Inc. has entered into a definitive agreement to acquire Personalis, Inc. for $16.25 per…

What You Should Know Blue Cross Blue Shield of Massachusetts (“Blue Cross”) has formalized its first-ever specialty-specific, outcomes-based value-based contract…

What You Should Know Oncology AI innovator Triomics has announced a $22M Series B financing round led by Battery Ventures,…

AI-powered pre-screening infrastructure enables scalable, privacy-preserving clinical trial matching across underserved patient populations in the Atlanta region. BOCA RATON, Fla.–(BUSINESS…

What You Should Know Moffitt Cancer Center has announced the expansion of its hybrid virtual oncology care program with Reimagine…

EHR-enabled access has the potential to streamline ordering, accelerate clinical decisions, and drive scalable precision oncology adoption FORT MYERS, Fla.–(BUSINESS…